One of the users (posting here:http://www.hairlosscure2020.com/spironolactone/) managed to contact Replicel and asked them about phase 2 and their presence during last dermatological congress. Here is their reply:
Thank you for your questions. We are still working towards conducting a phase 2 trial in Germany for RCH-01 and hope to have it started before the end of this year. You are correct about Shiseido, and we expect that they will be able to get their trial started ahead of the German start date. At this time, we will not be conducting a phase 2 trial in North America, only in Germany. If our phase 2 data is favorable, we will look to sell the data package to a much larger pharmaceutical company who has more experience bring products to market. They would need to conduct a multi-site phase 3 trial which would need to include North America if they wanted to sell RCH-01 in North America.
The Derm conference was a huge success. Two of our doctors, Dr. Kevin McElwee and Dr. Rolf Hoffmann both presented. I’ve attached a copy of the poster that Dr. McElwee presented, Dr. Hoffmann chaired a session.
I hope this answers your questions. I hope you have a wonderful day.
Kind Regards,
The Derm conference was a huge success. Two of our doctors, Dr. Kevin McElwee and Dr. Rolf Hoffmann both presented. I’ve attached a copy of the poster that Dr. McElwee presented, Dr. Hoffmann chaired a session.
I hope this answers your questions. I hope you have a wonderful day.
Kind Regards,
Comment